This guidance in brief complements the joint guidance, ‘Prevention and control of infectious diseases among people who inject drugs – 2023 update’.
It is available in all EU/EEA languages and provides an overview of the 2023 guidance developed by ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The full guidance aims to support policy-makers and public health/social programme planners by strengthening the evidence base for developing national strategies, policies, and programmes for preventing and controlling infections and infectious diseases among people who inject drugs.
Access the guidance in brief here.
Access the full guidance here.
Related HIV and Co-Infections News
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
-
EurekAlert!: Between 2.4 and 4.1 million people estimated to be living with chronic hepatitis B infection in Europe
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.